Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Simonneau

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
Annals of the Rheumatic Diseases|March 19, 2009
Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung diseaseB Terrier, M C Tamby, L Camoin, et al.
The European Respiratory Journal|April 16, 2004
Chronic thromboembolic pulmonary hypertensionP Dartevelle, E Fadel, S Mussot, et al.
The European Respiratory Journal|August 9, 2002
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesisM Humbert, P Labrune, O Sitbon, et al.
The New England Journal of Medicine|September 4, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie PulmonaireG Simonneau, H Sors, B Charbonnier, et al.
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Role of nitric oxide in hepatopulmonary syndrome in cirrhotic ratsH Nunes, D Lebrec, M Mazmanian, et al.
Lancet (London, England)|October 13, 2001
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled studyR N Channick, G Simonneau, O Sitbon, et al.
The European Respiratory Journal|October 3, 2002
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivativesM Humbert, Z Deng, G Simonneau, et al.
The New England Journal of Medicine|March 14, 1996
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study GroupM M Koopman, P Prandoni, F Piovella, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Surgical treatment of chronic thromboembolic pulmonary hypertension]P Dartevelle, E Fadel, S Mussot, et al.
Arthritis and Rheumatism|May 3, 2012
Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertensionS Günther, X Jaïs, S Maitre, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Annals of the Rheumatic Diseases|March 19, 2009
Antifibroblast antibodies from systemic sclerosis patients bind to {alpha}-enolase and are associated with interstitial lung diseaseB Terrier, M C Tamby, L Camoin, et al.
The European Respiratory Journal|April 16, 2004
Chronic thromboembolic pulmonary hypertensionP Dartevelle, E Fadel, S Mussot, et al.
The European Respiratory Journal|August 9, 2002
Pulmonary arterial hypertension and type-I glycogen-storage disease: the serotonin hypothesisM Humbert, P Labrune, O Sitbon, et al.
The New England Journal of Medicine|September 4, 1997
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie PulmonaireG Simonneau, H Sors, B Charbonnier, et al.
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Role of nitric oxide in hepatopulmonary syndrome in cirrhotic ratsH Nunes, D Lebrec, M Mazmanian, et al.
Lancet (London, England)|October 13, 2001
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled studyR N Channick, G Simonneau, O Sitbon, et al.
The European Respiratory Journal|October 3, 2002
BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivativesM Humbert, Z Deng, G Simonneau, et al.
The New England Journal of Medicine|March 14, 1996
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study GroupM M Koopman, P Prandoni, F Piovella, et al.
Presse Medicale (Paris, France : 1983)|November 23, 2005
[Surgical treatment of chronic thromboembolic pulmonary hypertension]P Dartevelle, E Fadel, S Mussot, et al.
Arthritis and Rheumatism|May 3, 2012
Computed tomography findings of pulmonary venoocclusive disease in scleroderma patients presenting with precapillary pulmonary hypertensionS Günther, X Jaïs, S Maitre, et al.
Pageof 24